Bente Kilhovd

Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease.

Bente Kilhovd, Tore Julsrud Berg, K. I. Birkeland et al. · Diabetes Care · 1999 · 265 citations

Increased serum levels of the specific AGE-compound methylglyoxal-derived hydroimidazolone in patients with type 2 diabetes

Bente Kilhovd, Ida Giardino, Peter A. Torjesen et al. · Metabolism · 2003 · 186 citations

Metabolic Syndrome, Diabetes Management, Diabetes +6

Increased serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18 year follow-up study

Bente Kilhovd, Auni Juutilainen, Seppo Lehto et al. · Diabetologia · 2007 · 163 citations · Full text

Metabolic Syndrome, Diabetes Epidemiology, Cardiovascular Disease +9

Increased serum levels of the specific advanced glycation end product methylglyoxal-derived hydroimidazolone are associated with retinopathy in patients with type 2 diabetes mellitus

Dag Sigurd Fosmark, Peter A. Torjesen, Bente Kilhovd et al. · Metabolism · 2006 · 123 citations · Full text

Metabolic Syndrome, Diabetic Retinopathy, Ocular Disease +9

High Serum Levels of Advanced Glycation End Products Predict Increased Coronary Heart Disease Mortality in Nondiabetic Women but not in Nondiabetic Men

Bente Kilhovd, Auni Juutilainen, Seppo Lehto et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2005 · 123 citations